Clinical Research, Pharma & Healthcare FinancingCalluna Pharma Names Gijs van den Brink as DirectorBusiness WireDecember 16, 2025December 18, 2025 by Business WireDecember 16, 2025December 18, 2025024 Calluna Pharma AS, a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced that Gijs van den Brink, MD,...